Four-Year Follow-Up of TYPHOON (Trial to Assess the Use of the CYPHer Sirolimus-Eluting Coronary Stent in Acute Myocardial Infarction Treated With BallOON Angioplasty)

被引:91
作者
Spaulding, Christian [1 ,2 ]
Teiger, Emmanuel [3 ]
Commeau, Philippe [4 ]
Varenne, Olivier [2 ]
Bramucci, Ezio [5 ]
Slama, Michel [6 ]
Beatt, Keavin [7 ]
Tirouvanziam, Ashok [8 ]
Polonski, Lech [9 ]
Stella, Pieter R. [10 ]
Clugston, Richard [11 ]
Fajadet, Jean [12 ]
de Boisgelin, Xavier [13 ]
Bode, Christophe [14 ]
Carrie, Didier [15 ]
Erglis, Andrejs [16 ]
Merkely, Bela [17 ]
Hosten, Stefan [18 ]
Cebrian, Ana [18 ]
Wang, Patrick [18 ]
Stoll, Hans-Peter [18 ]
Henry, Patrick [19 ]
机构
[1] Paris Descartes Univ, Dept Cardiol, Cochin Hosp, Assistance Publ Hop Paris, F-75014 Paris, France
[2] INSERM, U970, Paris, France
[3] Henri Mondor Hosp, Assistance Publ Hop Paris, Paris, France
[4] Polyclin Fleurs, Ollioules, France
[5] Policlin S Matteo Pavia, Pavia, Italy
[6] Hop Antoine Beclere, Clamart, France
[7] Mayday Univ Hosp, London, England
[8] CHU Nantes, Hop Guillaume & Rene Laennec, F-44035 Nantes 01, France
[9] Slaskie Ctr Chorob Serca, Zabrze, Poland
[10] Heart Lung Ctr, Univ Med Ctr, Utrecht, Netherlands
[11] Royal Perth Hosp, Perth, WA, Australia
[12] Clin Pasteur, Toulouse, France
[13] Clin Millenaire, Montpellier, France
[14] Univ Freiburg Klinikum, Freiburg, Germany
[15] Hop Rangueil, Toulouse, France
[16] Pauls Stradins Univ Hosp, Riga, Latvia
[17] Semmelweis Univ, Budapest, Hungary
[18] Cordis Corp Johnson & Johnson, Waterloo, Belgium
[19] Hop Lariboisiere, F-75475 Paris, France
关键词
bare-metal stent; percutaneous coronary intervention; sirolimus-eluting coronary stent; target lesion revascularization; BARE-METAL STENTS; UNCOATED STENTS; CLINICAL-PRACTICE; THROMBOSIS; CLOPIDOGREL; IMPLANTATION; PLACEMENT; OUTCOMES; THERAPY; DISCONTINUATION;
D O I
10.1016/j.jcin.2010.10.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The aim of this study was to assess the long-term safety and efficacy of the CYPHER (Cordis, Johnson and Johnson, Bridgewater, New Jersey) sirolimus-eluting coronary stent (SES) in percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). Background Concern over the safety of drug-eluting stents implanted during PCI for STEMI remains, and long-term follow-up from randomized trials are necessary. TYPHOON (Trial to assess the use of the cYPHer sirolimus-eluting stent in acute myocardial infarction treated with ballOON angioplasty) randomized 712 patients with STEMI treated by primary PCI to receive either SES (n = 355) or bare-metal stents (BMS) (n = 357). The primary end point, target vessel failure at 1 year, was significantly lower in the SES group than in the BMS group (7.3% vs. 14.3%, p = 0.004) with no increase in adverse events. Methods A 4-year follow-up was performed. Complete data were available in 501 patients (70%), and the survival status is known in 580 patients (81%). Results Freedom from target lesion revascularization (TLR) at 4 years was significantly better in the SES group (92.4% vs. 85.1%; p = 0.002); there were no significant differences in freedom from cardiac death (97.6% and 95.9%; p = 0.37) or freedom from repeat myocardial infarction (94.8% and 95.6%; p = 0.85) between the SES and BMS groups. No difference in definite/probable stent thrombosis was noted at 4 years (SES: 4.4%, BMS: 4.8%, p = 0.83). In the 580 patients with known survival status at 4 years, the all-cause death rate was 5.8% in the SES and 7.0% in the BMS group (p = 0.61). Conclusions In the 70% of patients with complete follow-up at 4 years, SES demonstrated sustained efficacy to reduce TLR with no difference in death, repeat myocardial infarction or stent thrombosis. (The Study to Assess AMI Treated With Balloon Angioplasty [TYPHOON]; NCT00232830) (J Am Coll Cardiol Intv 2011;4: 14-23) (C) 2011 by the American College of Cardiology Foundation
引用
收藏
页码:14 / 23
页数:10
相关论文
共 36 条
[11]   Pathological correlates of late drug-eluting stent thrombosis - Strut coverage as a marker of endothelialization [J].
Finn, Aloke V. ;
Joner, Michael ;
Nakazawa, Gaku ;
Kolodgie, Frank ;
Newell, John ;
John, Mike C. ;
Gold, Herman K. ;
Virmani, Renu .
CIRCULATION, 2007, 115 (18) :2435-2441
[12]   Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction [J].
Kastrati, Adnan ;
Dibra, Alban ;
Spaulding, Christian ;
Laarman, Gerrit J. ;
Menichelli, Maurizio ;
Valgimigli, Marco ;
Di Lorenzo, Emilio ;
Kaiser, Christoph ;
Tierala, Ilkka ;
Mehilli, Julinda ;
Seyfarth, Melchior ;
Varenne, Olivier ;
Dirksen, Maurits T. ;
Percoco, Gianfranco ;
Varricchio, Attilio ;
Pittl, Undine ;
Syvanne, Mikko ;
Suttorp, Maarten J. ;
Violini, Roberto ;
Schoemig, Albert .
EUROPEAN HEART JOURNAL, 2007, 28 (22) :2706-2713
[13]   Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials [J].
Keeley, EC ;
Boura, JA ;
Grines, CL .
LANCET, 2006, 367 (9510) :579-588
[14]   Drug-eluting versus bare metal stents in patients with ST-segment-elevation myocardial infarction -: Eight-month follow-up in the drug elution and distal protection in acute myocardial infarction (DEDICATION) trial [J].
Kelbaek, Henning ;
Thuesen, Leif ;
Helqvist, Steffen ;
Clemmensen, Peter ;
Klovgaard, Lene ;
Kaltoft, Anne ;
Andersen, Bente ;
Thuesen, Helle ;
Engstrom, Thomas ;
Botker, Hans E. ;
Saunamaeki, Kari ;
Krusell, Lars R. ;
Jorgensen, Erik ;
Hansen, Hans-Henrik T. ;
Christiansen, Evald H. ;
Ravkilde, Jan ;
Kober, Lars ;
Kofoed, Klaus F. ;
Terkelsen, Christian J. ;
Lassen, Jens F. .
CIRCULATION, 2008, 118 (11) :1155-1162
[15]  
King Spencer B 3rd, 2008, J Am Coll Cardiol, V51, P172, DOI 10.1016/j.jacc.2007.10.002
[16]   Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention [J].
Laarman, Gerrit J. ;
Suttorp, Maarten J. ;
Dirksen, Maurits T. ;
van Heerebeek, Loek ;
Kiemeneij, Ferdinand ;
Slagboom, Ton ;
van der Wieken, L. Ron ;
Tijssen, Jan G. P. ;
Rensing, Benno J. ;
Patterson, Mark .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (11) :1105-1113
[17]   Drug-eluting or bare-metal stents for acute myocardial infarction [J].
Mauri, Laura ;
Silbaugh, Treacy S. ;
Garg, Pallav ;
Wolf, Robert E. ;
Zelevinsky, Katya ;
Lovett, Ann ;
Varma, Manu R. ;
Zhou, Zheng ;
Normand, Sharon-Lise T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) :1330-1342
[18]   Stent thrombosis in randomized clinical trials of drug-eluting stents [J].
Mauri, Laura ;
Hsieh, Wen-hua ;
Massaro, Joseph M. ;
Ho, Kalon K. L. ;
D'Agostino, Ralph ;
Cutlip, Donald E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (10) :1020-1029
[19]   Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study [J].
Mehta, SR ;
Yusuf, S ;
Peters, RJG ;
Bertrand, ME ;
Lewis, BS ;
Natarajan, MK ;
Maimberg, K ;
Rupprecht, HJ ;
Zhao, F ;
Chrolavicius, S ;
Copland, I ;
Fox, KAA .
LANCET, 2001, 358 (9281) :527-533
[20]   Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI) [J].
Menichelli, Maurizio ;
Parma, Antonio ;
Pucci, Edoardo ;
Fiorilli, Rosario ;
De Felice, Francesco ;
Nazzaro, Marco ;
Giulivi, Alessia ;
Alborino, Domenico ;
Azzellino, Arianna ;
Violini, Roberto .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (19) :1924-1930